R&D | March 19, 2026
IIT Roorkee unveils cutting-edge molecular medicine facility
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
ILUMYA has already earned FDA approvals for scalp and nail plaque psoriasis in April 2024 and December 2025
Cadila Pharmaceuticals’ journey has been marked by several milestones, including the development of indigenous formulations, expansion into global markets, and the creation of robust manufacturing and R&D capabilities
The facility will manufacture the critical antibiotic intermediate Amino Cephalosporanic Acid (ACA), a key component in the production of cephalosporin antibiotics
Desidustat tablets are a novel oral HIF-PHI approved for treating anaemia in non-dialysis adult CKD patients
The endorsement follows overwhelming support for the share swap preceding the merger,
The move comes as the global biotech and biopharma CDMO market continues to surge, fueled by rising demand
Remidex manufactures micronutrient premixes and nutraceuticals,
Launches advanced bone density systems in India & Dubai
The NeuroSakhi initiative aims to close these gaps by strengthening awareness, building patient support networks and improving engagement between healthcare professionals, patients and caregivers across Punjab
Subscribe To Our Newsletter & Stay Updated
